ARTL
Artelo BiosciencesยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
ARTL Profile
Artelo Biosciences, Inc.
A clinical-stage biopharmaceutical company developing cannabinoid-based therapies for cancer, pain, and inflammatory diseases
505 Lomas Santa Fe
, Suite 160
, Solana Beach
, CA USA 92075
--
Artelo Biosciences, Inc., was incorporated in Nevada on May 2, 2011. The Company is a clinical biopharmaceutical company dedicated to the development and commercialization of therapies designed to modulate endogenous signaling pathways, including the endocannabinoid system (" ECS "), an array of receptors and neurotransmitters that form a biochemical communication network throughout the body.
